Literature DB >> 19330483

Quantification of dispersion of Gd-DTPA from the initial area of enhancement into the peritumoral zone of edema in brain tumors.

Igor N Pronin1, Kathleen A McManus, Andrei I Holodny, Kyung K Peck, Valeri N Kornienko.   

Abstract

To evaluate Gd-DTPA contrast enhancement of brain tumors over time and to describe the dispersion of contrast into the zone of peritumoral edema. We performed MR imaging with a dose of 0.4 mmol Gd-DTPA/kg on eleven patients diagnosed with 5 different supratentorial tumors. MR imaging was done at five intervals between 5 min and 6 h. The change in zone of enhancement was measured for each time point, and a linear measurement was made of the furthest dispersion of contrast from the original volume of enhancement. An increase in the zone of enhancement over time was seen for all tumors; the average increase in volume of contrast was 14.76 +/- 3.35 cm(3) (mean +/- standard deviation). The largest changes in the zone of contrast enhancement, 18.6 +/- 4.63 cm(3), were seen in glioblastoma multiforme. The expansion of contrast enhancement assumed the morphology of the surrounding edema. The dispersion of Gd-DTPA over time into the zone of peritumoral edema is a potential source of error in clinical settings when there is a delay between Gd-DTPA injection and scanning.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19330483     DOI: 10.1007/s11060-009-9872-x

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  39 in total

1.  Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma.

Authors:  R J Ott; M Brada; M A Flower; J W Babich; S R Cherry; B J Deehan
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

Review 2.  Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.

Authors:  P S Tofts
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

3.  Quantitative analysis of brain edema resolution into the cerebral ventricles and subarachnoid space.

Authors:  E Wrba; V Nehring; R C Chang; A Baethmann; H J Reulen; E Uhl
Journal:  Acta Neurochir Suppl       Date:  1997

4.  Triple-dose contrast/magnetization transfer suppressed imaging of 'non-enhancing' brain gliomas.

Authors:  Bradley J Erickson; Norbert G Campeau; Shawn A Schreiner; Jan C Buckner; Brian P O'Neill; Judith R O'Fallon
Journal:  J Neurooncol       Date:  2002-10       Impact factor: 4.130

5.  Role of hydrodynamic processes in the pathogenesis of peritumoral brain edema in meningiomas.

Authors:  M Bitzer; T Nägele; B Geist-Barth; U Klose; E Grönewäller; M Morgalla; E Heiss; K Voigt
Journal:  J Neurosurg       Date:  2000-10       Impact factor: 5.115

Review 6.  Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Peter L Choyke; Andrew J Dwyer; Michael V Knopp
Journal:  J Magn Reson Imaging       Date:  2003-05       Impact factor: 4.813

7.  In vivo CT measurement of blood-brain transfer constant of iopamidol in human brain tumors.

Authors:  W T Yeung; T Y Lee; R F Del Maestro; R Kozak; T Brown
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

8.  Dynamics of formation and resolution of vasogenic brain oedema. I. Measurement of oedema clearance into ventricular CSF.

Authors:  M Tsuyumu; H J Reulen; G Prioleau
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

9.  Boron neutron capture therapy for malignant tumors related to meningiomas.

Authors:  Shin-ichi Miyatake; Yoji Tamura; Shinji Kawabata; Kyoko Iida; Toshihiko Kuroiwa; Koji Ono
Journal:  Neurosurgery       Date:  2007-07       Impact factor: 4.654

10.  Contrast-enhanced MR imaging of malignant brain tumors.

Authors:  M Graif; G M Bydder; R E Steiner; P Niendorf; D G Thomas; I R Young
Journal:  AJNR Am J Neuroradiol       Date:  1985 Nov-Dec       Impact factor: 3.825

View more
  7 in total

1.  Peritumoral tissue compression is predictive of exudate flux in a rat model of cerebral tumor: an MRI study in an embedded tumor.

Authors:  James R Ewing; Tavarekere N Nagaraja; Madhava P Aryal; Kelly A Keenan; Rasha Elmghirbi; Hassan Bagher-Ebadian; Swayamprava Panda; Mei Lu; Tom Mikkelsen; Glauber Cabral; Stephen L Brown
Journal:  NMR Biomed       Date:  2015-10-01       Impact factor: 4.044

Review 2.  Targeted imaging and therapy of brain cancer using theranostic nanoparticles.

Authors:  Mahaveer Swaroop Bhojani; Marcian Van Dort; Alnawaz Rehemtulla; Brian D Ross
Journal:  Mol Pharm       Date:  2010-10-27       Impact factor: 4.939

3.  Local Glioma Cells Are Associated with Vascular Dysregulation.

Authors:  S G Bowden; B J A Gill; Z K Englander; C I Horenstein; G Zanazzi; P D Chang; J Samanamud; A Lignelli; J N Bruce; P Canoll; J Grinband
Journal:  AJNR Am J Neuroradiol       Date:  2018-01-25       Impact factor: 3.825

4.  High Precision Imaging of Microscopic Spread of Glioblastoma with a Targeted Ultrasensitive SERRS Molecular Imaging Probe.

Authors:  Ruimin Huang; Stefan Harmsen; Jason M Samii; Hazem Karabeber; Kenneth L Pitter; Eric C Holland; Moritz F Kircher
Journal:  Theranostics       Date:  2016-05-07       Impact factor: 11.556

5.  Dendrimer-Based Nanomedicine (Paramagnetic Nanoparticle, Nanocombretastatin, Nanocurcumin) for Glioblastoma Multiforme Imaging and Therapy.

Authors:  Stephen L Brown; James M Snyder; Meser M Ali
Journal:  Nov Approaches Cancer Study       Date:  2021-10-20

6.  Guiding brain tumor resection using surface-enhanced Raman scattering nanoparticles and a hand-held Raman scanner.

Authors:  Hazem Karabeber; Ruimin Huang; Pasquale Iacono; Jason M Samii; Ken Pitter; Eric C Holland; Moritz F Kircher
Journal:  ACS Nano       Date:  2014-08-22       Impact factor: 15.881

7.  Application of Dendrimer-based Nanoparticles in Glioma Imaging.

Authors:  Sunalee Gonawala; Meser M Ali
Journal:  J Nanomed Nanotechnol       Date:  2017-06-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.